KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56a to initiate pancreatic cancer development
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 34 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 34 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer developmentOncogene · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE250101_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1052021 and SRA study SRP477316. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 34 samples.
How we read this: 12 replicated groups read from 34 sample titles; they account for 34 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7966164 KCBKO_D1_1 KCBKO_D1
- GSM7966165 KCBKO_D1_2 KCBKO_D1
- GSM7966166 KCBKO_D2_1 KCBKO_D2
- GSM7966167 KCBKO_D2_2 KCBKO_D2
- GSM7966168 KCBKO_D2_3 KCBKO_D2
- GSM7966169 KCBKO_D3_1 KCBKO_D3
- GSM7966170 KCBKO_D3_2 KCBKO_D3
- GSM7966171 KCBKO_D3_3 KCBKO_D3
- GSM7966172 KC_D3_1 KC_D3
- GSM7966173 KC_D3_2 KC_D3
- GSM7966174 KC_D3_3 KC_D3
- GSM7966175 KC_D2_1 KC_D2
- GSM7966176 KC_D2_2 KC_D2
- GSM7966177 KC_D2_3 KC_D2
- GSM7966178 KC_D1_1 KC_D1
- GSM7966179 KC_D1_3 KC_D1
- GSM7973966 KC_D1_BiolRep1 KC_D1_Biol
- GSM7973967 KC_D1_BiolRep2 KC_D1_Biol
- GSM7973968 KC_D1_BiolRep3 KC_D1_Biol
- GSM7973969 KC_D2_BiolRep1 KC_D2_Biol
- GSM7973970 KC_D2_BiolRep2 KC_D2_Biol
- GSM7973971 KC_D2_BiolRep3 KC_D2_Biol
- GSM7973972 KC_D3_BiolRep1 KC_D3_Biol
- GSM7973973 KC_D3_BiolRep2 KC_D3_Biol
- GSM7973974 KC_D3_BiolRep3 KC_D3_Biol
- GSM7973975 KCB_D1_BiolRep1 KCB_D1_Biol
- GSM7973976 KCB_D1_BiolRep2 KCB_D1_Biol
- GSM7973977 KCB_D1_BiolRep3 KCB_D1_Biol
- GSM7973978 KCB_D2_BiolRep1 KCB_D2_Biol
- GSM7973979 KCB_D2_BiolRep2 KCB_D2_Biol
- GSM7973980 KCB_D2_BiolRep3 KCB_D2_Biol
- GSM7973981 KCB_D3_BiolRep1 KCB_D3_Biol
- GSM7973982 KCB_D3_BiolRep2 KCB_D3_Biol
- GSM7973983 KCB_D3_BiolRep3 KCB_D3_Biol
- GSE250099 KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56a to initiate pancreatic cancer development [ATAC-seq] 18 samples shares pp2a-b56a, cip2a, kras-mediated, upregulation, suppression, pancreatic, promotes, initiate
- GSE249867 KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56a to initiate pancreatic cancer development [RNA-Seq] 16 samples shares pp2a-b56a, cip2a, kras-mediated, upregulation, suppression, pancreatic, promotes, initiate
- GSE245607 WWOX promotes osteosarcoma development via upregulation of Myc 39 samples shares upregulation, promotes
- GSE245605 WWOX promotes osteosarcoma development via upregulation of Myc [RNA-Seq] 37 samples shares upregulation, promotes
- GSE278349 LSD1 inhibition promotes CD8+ T cells mediated anti-tumor immunity by MHC-I upregulation and enhanced infiltration of dendritic cells through IFNγ-CXCL9-CXCR3 axis 10 samples shares upregulation, promotes
- GSE305592 Transcriptomic Analysis Reveals TME-Mediated Macrophage IFIT1 Upregulation and CX3CR1 Suppression Drive Osteosarcoma Progression 9 samples shares upregulation, suppression
- GSE263095 Dynamic upregulation of retinoic acid RA signal in the early postnatal murine heart promotes cardiomyocyte cell cycle exit and maturation 8 samples shares upregulation, promotes
- GSE287676 mTORC1 promotes adipose tissue ILC2 homeostasis through upregulation of PPARγ 4 samples shares upregulation, promotes
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.